Litigation Details for ELI LILLY AND COMPANY v. SUNSHINE LAKE PHARMA CO., LTD. (D.N.J. 2018)
✉ Email this page to a colleague
ELI LILLY AND COMPANY v. SUNSHINE LAKE PHARMA CO., LTD. (D.N.J. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-04-09 |
Court | District Court, D. New Jersey | Date Terminated | 2018-08-16 |
Cause | 35:271 Patent Infringement | Assigned To | William H. Walls |
Jury Demand | None | Referred To | Cathy L. Waldor |
Patents | 6,943,166 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in ELI LILLY AND COMPANY v. SUNSHINE LAKE PHARMA CO., LTD.
Details for ELI LILLY AND COMPANY v. SUNSHINE LAKE PHARMA CO., LTD. (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-04-09 | 1 | e)(2) for infringement of U.S. Patent No. 6,943,166 (“the ’166 patent”). Case 2:18-cv-05765-WHW-CLW Document… 1. This is an action for patent infringement arising under the patent laws of the United States, … PATENT-IN-SUIT 27. On September 13, 2005, the U.S. Patent and Trademark Office…copy of the ’166 patent is attached hereto as Exhibit A. The claims of the ’166 patent are valid and enforceable…and 20 mg dosage strengths. The ’166 patent is one of the patents listed in the FDA publication entitled | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |